We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Automated Phone Speech Test Identifies Alzheimer’s Pathology for Prescreening

By HospiMedica International staff writers
Posted on 22 May 2026

Alzheimer’s disease assessment and trial recruitment often rely on costly, invasive biomarker testing and clinic-based cognitive evaluations, limiting scalability as populations age. More...

Providers and trial sponsors need remote tools that can help triage candidates and monitor cognition without requiring in-person visits. A new automated, phone-based speech biomarker now offers a scalable approach for detecting cognitive impairment and signals of underlying Alzheimer’s pathology across multiple languages.

ki:elements’ (Saarbrücken, Germany) Speech Biomarker for Cognition (SB-C) was evaluated in peer-reviewed research conducted with the PROSPECT-AD consortium. The assessment is delivered via the Mili platform, which places a phone call to participants at home and administers a 10-minute task through an AI voice agent. The study enrolled 736 participants across five independent cohorts in Spain, the UK, Germany, and Sweden.

SB-C analyzes 70 distinct speech features to index cognitive efficiency and generate an automatic biomarker score. The approach distinguished cognitively unimpaired individuals from those with mild cognitive impairment (MCI) or early dementia and classified cerebrospinal fluid biomarker status remotely. Performance included identification of amyloid-beta positivity with an AUC of up to 0.74 and phosphorylated tau 181 positivity with an AUC of up to 0.82.

The tool showed multilingual sensitivity across Spanish, Catalan, German, English, and Swedish. It demonstrated strong convergent validity with established measures such as MMSE and PACC-5 and is validated following the Digital Medicine Society’s V3 Framework. It is currently deployed as a pre-screening tool in multiple Alzheimer’s disease clinical trials to enrich for biomarker‑positive participants prior to invasive testing.

“This study gives us real-world, multi-site evidence that a speech assessment can track with established cognitive measures and distinguish patients by their underlying pathology. For sponsors, this translates directly into faster, smarter recruitment, and a lower-burden tool for participants,” said Dr. Alexandra König, Chief Clinical Research Officer of ki:elements and corresponding author of the study.

Related Links
ki:elements


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.